19.96%SPY 79.52 
5.39%XLF 9.68 3.09%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
NEW BRUNSWICK, N.J. - Health care products maker Johnson & Johnson says a federal court has entered a final judgment of about $1.2 billion in favor of Cordis Corp., its heart device unit, in a patent dispute.
The dispute involves Boston Scientific Corp. and Medtronic Inc., two rival makers of stents, tiny metal-mesh scaffolds that prop open heart arteries after they have been cleared.
The judgment was issued by the U.S. District Court in Delaware on Tuesday, according to Johnson & Johnson.
The company said juries in 2000 and again in 2005 found that bare metal stents made by Boston Scientific and Medtronic infringed on Cordis Corp.'s patent for its Palmaz stent.
Boston Scientific was ordered to pay $703 million and Medtronic, about $521 million.
China's bid to establish its own next generation mobile phone technology standard got a boost from the world's biggest cell phone maker...
U.S stocks fell on Wednesday as investors grew concerned that a bailout loan package for ailing automakers would fail to be approved by U.S. lawm...
An international meeting has set new guidelines aimed at preventing tobacco companies from trying to influence national and global health policy....
Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Split Big Profits! You Find it & We Fund it! Co-Own Or Cash Out! Get Free Info Kit Now!
Get your next web design project done with our los angeles web design team - Best web design with great price.
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
